Biomarin Pharmaceutical Inc (BMRN) — Free Cash Flow Generation Index
Biomarin Pharmaceutical Inc (BMRN) has a Free Cash Flow Generation Index of 0.59x as of December 2025. Free cash flow of $58.92 Million represents 1% of operating cash flow ($99.64 Million). See Biomarin Pharmaceutical Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Biomarin Pharmaceutical Inc Free Cash Flow Generation Index (2009–2025)
Historical FCF Generation Index trend for Biomarin Pharmaceutical Inc across 12 annual periods. Explore BMRN operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Biomarin Pharmaceutical Inc (2009–2025)
Year-by-year Free Cash Flow Generation Index for Biomarin Pharmaceutical Inc. For the full company profile including market capitalisation, see how much is Biomarin Pharmaceutical Inc worth.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.88x | $724.96 Million | $827.99 Million | $103.04 Million | ▲ +5.5% |
| 2024 | 0.83x | $475.42 Million | $572.84 Million | $97.42 Million | ▲ +111.3% |
| 2023 | 0.39x | $62.57 Million | $159.26 Million | $96.69 Million | ▲ +25.8% |
| 2022 | 0.31x | $54.94 Million | $175.90 Million | $120.96 Million | ▼ -48.7% |
| 2021 | 0.61x | $185.31 Million | $304.54 Million | $119.22 Million | ▲ +199.6% |
| 2020 | -0.61x | $-52.15 Million | $85.36 Million | $137.52 Million | ▲ +69.5% |
| 2019 | -2.00x | $-96.76 Million | $48.26 Million | $145.03 Million | ▲ +67.4% |
| 2018 | -6.16x | $-124.41 Million | $20.21 Million | $144.62 Million | ▼ -302.1% |
| 2012 | -1.53x | $-26.96 Million | $17.61 Million | $44.57 Million | ▲ +78.8% |
| 2011 | -7.22x | $-135.47 Million | $18.75 Million | $154.22 Million | ▼ -340.9% |
| 2010 | -1.64x | $-30.71 Million | $18.75 Million | $49.46 Million | ▼ -6847.7% |
| 2009 | -0.02x | $-2.07 Million | $87.73 Million | $89.80 Million | — |